1. Home
  2. GCT vs PCRX Comparison

GCT vs PCRX Comparison

Compare GCT & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GigaCloud Technology Inc

GCT

GigaCloud Technology Inc

HOLD

Current Price

$38.01

Market Cap

1.2B

ML Signal

HOLD

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$25.49

Market Cap

999.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GCT
PCRX
Founded
2019
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
999.0M
IPO Year
2021
2010

Fundamental Metrics

Financial Performance
Metric
GCT
PCRX
Price
$38.01
$25.49
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
4
Target Price
$33.00
$30.25
AVG Volume (30 Days)
615.7K
448.9K
Earning Date
05-08-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
17.70
107.44
EPS
1.04
0.07
Revenue
$1,161,042,000.00
$541,533,000.00
Revenue This Year
$14.43
$6.78
Revenue Next Year
$6.78
$8.54
P/E Ratio
$36.50
$363.86
Revenue Growth
64.96
26.04
52 Week Low
$20.71
$18.80
52 Week High
$51.82
$27.64

Technical Indicators

Market Signals
Indicator
GCT
PCRX
Relative Strength Index (RSI) 63.52 60.55
Support Level $37.46 $22.03
Resistance Level $43.64 $26.94
Average True Range (ATR) 1.49 0.94
MACD 0.72 -0.03
Stochastic Oscillator 84.18 47.53

Price Performance

Historical Comparison
GCT
PCRX

About GCT GigaCloud Technology Inc

GigaCloud Technology Inc provides end-to-end and B2B e-commerce solutions for large parcel merchandise. Its B2B e-commerce platform, which is referred to as the GigaCloud Marketplace, integrates everything from discovery, payments, and logistics tools into one easy-to-use platform. It offers online and offline integrated cross-border transaction and delivery services for furniture and large merchandise. Its marketplace seamlessly connects manufacturers in Asia with resellers in the U.S., Asia, and Europe to execute cross-border transactions with confidence, speed, and efficiency. It offers a truly comprehensive solution that transports products from the manufacturer's warehouse to end customers, all at one fixed price. It earns the majority of its revenue from the United States.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: